EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSODEG00000016562
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSODEG00000003962
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSODEG00000015598
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 3a5-Like

Ensembl ID : ENSODEG00000000254
Gene Symbol: LOC101571068
2 Cross references
650 Possible Orthologues:

Cytochrome P450 3a6-Like

Ensembl ID : ENSODEG00000000537
Gene Symbol: LOC101576638
2 Cross references
631 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSODEG00000008480
Gene Symbol: CYP17A1
3 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSODEG00000007934
Gene Symbol: CYP19A1
3 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSODEG00000006141
Gene Symbol: CYP26A1
3 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSODEG00000009054
Gene Symbol: CYP46A1
3 Cross references
259 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSODEG00000013160
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase-Like

Ensembl ID : ENSODEG00000020513
Gene Symbol: LOC101562780
2 Cross references
350 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSODEG00000015071
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).